| The energetic brain–A review from students to students MP Bordone, MM Salman, HE Titus, E Amini, JV Andersen, B Chakraborti, ... Journal of neurochemistry 151 (2), 139-165, 2019 | 173 | 2019 |
| ADAM17-mediated shedding of inflammatory cytokines in hypertension TM De Queiroz, N Lakkappa, E Lazartigues Frontiers in Pharmacology 11, 535849, 2020 | 56 | 2020 |
| Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson’s disease N Lakkappa, PT Krishnamurthy, MD Pandareesh, BD Hammock, ... Neurotoxicology 70, 135-145, 2019 | 31 | 2019 |
| Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders N Lakkappa, PT Krishnamurthy, BD Hammock, D Velmurugan, ... Medical hypotheses 93, 161-165, 2016 | 25 | 2016 |
| Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC–MS/MS method development N Lakkappa, PT Krishnamurthy, K Yamjala, SH Hwang, BD Hammock, ... Journal of pharmaceutical and biomedical analysis 149, 457-464, 2018 | 21 | 2018 |
| Nedd4-2 up-regulation is associated with ACE2 ubiquitination in hypertension M Mohammed, B Ogunlade, M Elgazzaz, C Berdasco, N Lakkappa, ... Cardiovascular Research 119 (11), 2130-2141, 2023 | 8 | 2023 |
| Investigating serum extracellular vesicles in Cystic Fibrosis A Trappe, N Lakkappa, S Carter, E Dillon, K Wynne, E McKone, P McNally, ... Journal of Cystic Fibrosis 22 (4), 674-679, 2023 | 1 | 2023 |
| ADAM17‐enriched Exosomes Contribute to Neuronal Activation in Hypertension N Lakkappa, J Xu, S Mukerjee, E Lazartigues The FASEB Journal 35, 2021 | 1 | 2021 |
| P170 Trikafta® modulates release of extracellular vesicles in cystic fibrosis N Lakkappa, K Lester, G Stone, P McNally, K Wynne, J Coppinger Journal of Cystic Fibrosis 22, S116-S117, 2023 | | 2023 |
| Selective blockade of AT1R and B1R modulates the expression of ACE2 ubiquitination partners N Lakkappa, E Lazartigues The FASEB Journal 36, 2022 | | 2022 |
| ACE2 Ubiquitination in the Paraventricular Nucleus of the Hypothalamus Contributes to Angiotensin‐II‐Induced Hypertension in Mice M Mohammed, M Elgazzaz, C Berdasco, N Lakkappa, MA Awoal, ... The FASEB Journal 36, 2022 | | 2022 |
| Abstract MP28: UBR1 And BRCC36 Regulate ACE2 Ubiquitination And Deubiquitination In Ang-II Induced Hypertension. N Lakkappa, C Berdasco, C Filipeanu, ED Lazartigues Hypertension 78 (suppl_1), AMP28-AMP28, 2021 | | 2021 |
| ACE2 Ubiquitination is Differentially Regulated by Sex Hormones in Hypertension N Lakkappa, M Elgazzaz, J Guidry, C Filipeanu, E Lazartigues The FASEB Journal 35, 2021 | | 2021 |
| The Energetic brain-A review from students to students (vol 151, 139, 2020) MP Bordone, MM Salman, HE Titus, E Amini, JV Andersen, B Chakraborti, ... JOURNAL OF NEUROCHEMISTRY 152 (6), 741-741, 2020 | | 2020 |
| sEH Inhibitor, APAU, Protects Dopaminergic Neurons against Rotenone Induced Toxicity N Lakkappa, P Krishnamurthy, PM Dasharatharao, BD Hammock, ... MOVEMENT DISORDERS 33, S105-S105, 2018 | | 2018 |
| Neuroprotective propensity of PTUPB, a dual inhibitor of sEH and COX-2 against rotenone induced neurotoxicity in cell line and Drosophila model of Parkinson's disease N Lakkappa, PT Krishnamurthy, PD Mirazkar, N Lakkappa, ... MOVEMENT DISORDERS 32, 2017 | | 2017 |
| Effect of electroconvulsive therapy on visuospatial memory in rats N Lakkappa, PT Krishnamurthy Parkinsonism & Related Disorders 22, e177-e178, 2016 | | 2016 |
| Pharmacological evaluation of dual soluble epoxide hydrolase and cox 2 inhibitors as potential antiparkinson agents N Lakkappa Mysore, 0 | | |
| The energetic brain-A review from students to students GB Freitas, D Gupta, R Gupta, M Jaggar, N Lakkappa, RK Paidi, ... | | |
